| Mortality | |
| Sudden cardiac death | 0 |
| Death due to non-cardiac causesa | 7 |
| Arrhythmic events | |
| aSCD and/or sustained VT/VF | 6 |
| Non-sustained ventricular tachycardia | 38 |
| Catheter ablation | 11 |
| First time device implantation | |
| Standard pacemaker | 2 |
| Implantable cardioverter-defibrillator | 16 |
| CRT-P | 1 |
| CRT-D | 1 |
| Heart failure events | |
| New-onset reduced LVEF ≤45% | 7 |
| LVAD/heart transplantation | 0 |
| Other cardiac events | |
| Hospital referrals for any cardiac symptom | 106 |
| Acute myocardial infarction | 4 |
| Mortality | |
| Sudden cardiac death | 0 |
| Death due to non-cardiac causesa | 7 |
| Arrhythmic events | |
| aSCD and/or sustained VT/VF | 6 |
| Non-sustained ventricular tachycardia | 38 |
| Catheter ablation | 11 |
| First time device implantation | |
| Standard pacemaker | 2 |
| Implantable cardioverter-defibrillator | 16 |
| CRT-P | 1 |
| CRT-D | 1 |
| Heart failure events | |
| New-onset reduced LVEF ≤45% | 7 |
| LVAD/heart transplantation | 0 |
| Other cardiac events | |
| Hospital referrals for any cardiac symptom | 106 |
| Acute myocardial infarction | 4 |
CRT, cardiac resynchronizing therapy; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction; SCD, sudden cardiac death; VF, ventricular fibrillation; VT, ventricular tachycardia.
Suicide (n = 1), accident (n = 1), upper gastrointestinal bleeding (n = 1), cancer (n = 3), and a ruptured abdominal aortic aneurysm (n = 1).
| Mortality | |
| Sudden cardiac death | 0 |
| Death due to non-cardiac causesa | 7 |
| Arrhythmic events | |
| aSCD and/or sustained VT/VF | 6 |
| Non-sustained ventricular tachycardia | 38 |
| Catheter ablation | 11 |
| First time device implantation | |
| Standard pacemaker | 2 |
| Implantable cardioverter-defibrillator | 16 |
| CRT-P | 1 |
| CRT-D | 1 |
| Heart failure events | |
| New-onset reduced LVEF ≤45% | 7 |
| LVAD/heart transplantation | 0 |
| Other cardiac events | |
| Hospital referrals for any cardiac symptom | 106 |
| Acute myocardial infarction | 4 |
| Mortality | |
| Sudden cardiac death | 0 |
| Death due to non-cardiac causesa | 7 |
| Arrhythmic events | |
| aSCD and/or sustained VT/VF | 6 |
| Non-sustained ventricular tachycardia | 38 |
| Catheter ablation | 11 |
| First time device implantation | |
| Standard pacemaker | 2 |
| Implantable cardioverter-defibrillator | 16 |
| CRT-P | 1 |
| CRT-D | 1 |
| Heart failure events | |
| New-onset reduced LVEF ≤45% | 7 |
| LVAD/heart transplantation | 0 |
| Other cardiac events | |
| Hospital referrals for any cardiac symptom | 106 |
| Acute myocardial infarction | 4 |
CRT, cardiac resynchronizing therapy; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction; SCD, sudden cardiac death; VF, ventricular fibrillation; VT, ventricular tachycardia.
Suicide (n = 1), accident (n = 1), upper gastrointestinal bleeding (n = 1), cancer (n = 3), and a ruptured abdominal aortic aneurysm (n = 1).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
